Pharmaceuticals

Autacoids And Related Drug Industry Overview 2025: Growth Projections and Market Trends

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Autacoids And Related Drug Market?

The autacoids and related drug market size has shown significant growth in recent years. This market is anticipated to expand from $50.15 billion in 2024 to $52.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. The expansion observed in prior periods can be attributed to factors such as the increasing incidence of inflammatory diseases, the rising utilization of prostaglandins in obstetrics, the widespread availability of antihistamine prescriptions, the broadening applications of serotonin agonists, and an elevated demand for medications that relieve migraines.

The autacoids and related drug market size is anticipated to demonstrate significant expansion in the coming years, with projections indicating it will climb to $66.2 billion in 2029, achieving a compound annual growth rate (CAGR) of 5.8%. This projected growth can be linked to factors such as an increasing geriatric population, the rising prevalence of chronic respiratory conditions, the adoption of personalized medicine, broadened healthcare access in developing economies, and an escalating incidence of cardiovascular disorders. Notable trends expected during the forecast period involve the integration of artificial intelligence in drug discovery, the development of dual-action autacoid medications, the embrace of biosimilars for autacoid treatments, an increase in self-medication and over-the-counter products, and the utilization of nanotechnology in drug formulation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

Which Drivers Are Shaping The Autacoids And Related Drug Industry’s Market Share?

The rising occurrence of cardiovascular ailments is anticipated to fuel the expansion of the autacoids and related drugs market in the future. These diseases encompass various conditions impacting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. A significant factor contributing to the growing prevalence of cardiovascular diseases is an unhealthy diet, given that overconsumption of saturated fats, trans fats, added sugars, and sodium leads to issues like high blood pressure, obesity, and elevated cholesterol, all critical risk factors for cardiac conditions. Autacoids and their associated drugs improve cardiovascular well-being by regulating vascular tone and inflammation, which is vital in managing conditions like hypertension and heart failure. Agents that target pathways involving nitric oxide, endothelin, and prostacyclin aid in restoring endothelial function, thereby encouraging vasodilation and decreasing vascular resistance. For instance, data from December 2023, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, indicates that doctor-certified deaths attributable to coronary heart disease (CHD) in Australia rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the rising incidence of cardiovascular diseases is propelling the expansion of the autacoids and related drugs market.

What Are The Different Segment Classifications Within The Autacoids And Related Drug Market?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2α (PGF2α) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

Which Market Trends Are Creating New Opportunities In The Autacoids And Related Drug Industry?

Leading pharmaceutical firms in the autacoids and associated medications sector are prioritizing the creation of novel products, including antihistamines, with the goal of improving treatment effectiveness, minimizing adverse reactions, and more accurately and safely treating evolving allergic and inflammatory ailments. These medications function by obstructing histamine, a chemical compound produced by the immune system in response to allergic reactions. An example of this is Tiefenbacher Pharmaceuticals, a German pharmaceutical company, which introduced Bilastine as an over-the-counter (OTC) drug in Germany in March 2023, thereby significantly enhancing availability of potent allergy therapies. The 20 mg Bilastine tablets provide a non-drowsy, second-generation antihistamine option for individuals experiencing allergic manifestations like hay fever and urticaria.

Which Major Firms Are Strengthening Their Position In The Autacoids And Related Drug Industry?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report

How Is Autacoids And Related Drug Market Demand Varying Across Different Regions?

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Autacoids And Related Drug Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp

Browse Through More Reports Similar to the Global Autacoids And Related Drug Market 2025, By The Business Research Company

Anti Hypertensive Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Antithrombotic Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/antithrombotic-drugs-market

Acne Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795